Get the Stockscreener App
12.45
0.00%
0.00
After Hours:
12.45
Kronos Worldwide Inc stock is traded at $12.45, with a volume of 129.39K.
It is up +0.00% in the last 24 hours and up +7.70% over the past month.
Kronos Worldwide Inc manufactures and sells titanium dioxide pigments. Titanium dioxide is a white inorganic pigment used in a variety of products. The majority of Kronos' sales come from titanium dioxide used for coatings on automobiles, aircraft, machines, appliances, traffic paint, and in both commercial and residential interiors and exteriors. The second-largest product category is titanium dioxide used for plastics such as packaging materials and food packaging, houseware, appliances, toys, and computer cases. The majority of revenue comes from the United States.
See More
Previous Close:
$12.45
Open:
$12.48
24h Volume:
129.39K
Relative Volume:
0.51
Market Cap:
$1.43B
Revenue:
$1.67B
Net Income/Loss:
$-49.10M
P/E Ratio:
-62.25
EPS:
-0.2
Net Cash Flow:
$-41.90M
1W Performance:
+8.73%
1M Performance:
+7.70%
6M Performance:
+5.51%
1Y Performance:
+60.65%
1-Day Range:
$12.31
$12.52
1-Week Range:
$11.29
$12.68
52-Week Range:
$6.16
$14.50
Kronos Worldwide Inc Stock (KRO) Company Profile
Name
Kronos Worldwide Inc
Sector
Industry
Phone
(972) 233-1700
Address
5430 LBJ FREEWAY, DALLAS, TX
Kronos Worldwide Inc Stock (KRO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-22 | Initiated | Goldman | Sell |
| Mar-28-17 | Downgrade | Standpoint Research | Buy → Hold |
| Mar-14-17 | Reiterated | Barclays | Underweight |
| Aug-28-15 | Reiterated | Barclays | Underweight |
| Aug-18-15 | Reiterated | Deutsche Bank | Hold |
| Feb-03-14 | Initiated | Barclays | Underweight |
| May-10-13 | Reiterated | Deutsche Bank | Hold |
| Mar-13-13 | Reiterated | Argus | Hold |
| Jan-03-13 | Downgrade | Oppenheimer | Outperform → Perform |
| Mar-02-12 | Initiated | Standpoint Research | Buy |
| Feb-22-12 | Downgrade | Deutsche Bank | Buy → Hold |
| May-05-11 | Reiterated | Deutsche Bank | Buy |
| Mar-08-11 | Reiterated | Deutsche Bank | Buy |
| Feb-11-11 | Reiterated | Oppenheimer | Outperform |
| Dec-03-10 | Reiterated | UBS | Buy |
| Dec-02-10 | Initiated | Deutsche Bank | Buy |
| Nov-30-10 | Initiated | BB&T Capital Mkts | Hold |
| Nov-08-10 | Initiated | Deutsche Bank | Buy |
View All
Kronos Worldwide Inc Stock (KRO) Latest News
Kronos Worldwide, Inc. (NYSE:KRO) Sees Large Increase in Short Interest - MarketBeat
American Century Companies Inc. Increases Position in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Renaissance Technologies LLC Buys 8,400 Shares of Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Kronos Worldwide (NYSE:KRO) Given New $10.00 Price Target at Barclays - MarketBeat
Financial Fitness Check: Examining Cronos Group Inc (CRON)’s Key Ratios - The Dwinnex
Kronos Bio to Present Data at ACR Convergence 2024 to - GlobeNewswire
Korro Bio, Inc. (NASDAQ:KRRO) Position Increased by NEA Management Company LLC - MarketBeat
Cronos Group (TSE:CRON) Stock Price Down 0.3% - Defense World
Keros Therapeutics Inc [KROS] Insider GORDON CARL L sells 250,000 Shares for $250,000 - Knox Daily
A new trading data show Cronos Group Inc (CRON) is showing positive returns. - SETE News
Keros Therapeutics Inc (KROS)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex
Get in on Gogo Inc’s (GOGO) buy-in window today! - SETE News
Titanium Dioxide Market is expected to generate a revenue of USD 25.39 Billion by 2031, Globally, at 6.40% CAGR: Verified Market Research® - GlobeNewswire Inc.
Keros Therapeutics (NASDAQ:KROS) Shares Gap Up to $55.80 - MarketBeat
How the (KROS) price action is used to our Advantage - Stock Traders Daily
How does Keros Therapeutics Inc (KROS) change from a tortoise to a hare? - SETE News
Kronos Bio highlights istisociclib data at Ovarian Cancer Research Symposium - TipRanks
71,428 Shares in Korro Bio, Inc. (NASDAQ:KRRO) Acquired by Tri Locum Partners LP - MarketBeat
Kronos Bio Highlights Data at AACR Ovarian Cancer Research - GlobeNewswire
Kronos Bio Highlights Data at AACR Ovarian Cancer Research Symposium that Supports Clinical Evaluation of Istisociclib in Advanced Ovarian Cancer - StockTitan
Keros Therapeutics (NASDAQ:KROS) Receives New Coverage from Analysts at Guggenheim - MarketBeat
Guggenheim starts Keros Therapeutics with 'buy' on lung disorder drug potential - XM
Iron Oxide Market Review: All Eyes on 2024 Outlook | KRONOS Worldwide, Applied Minerals, Yipin Pigments - openPR
Guggenheim bullish on Keros Therapeutics stock driven by PAH treatment prospects - Investing.com Australia
First Eagle Investment Management LLC Increases Holdings in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Kronos Worldwide, Inc. (NYSE:KRO) Shares Purchased by First Eagle Investment Management LLC - MarketBeat
Acadian Asset Management LLC Makes New Investment in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
(KRO) Trading Report - Stock Traders Daily
Kronos Worldwide, Inc. (NYSE:KRO) Shares Acquired by Quest Partners LLC - Defense World
Here's Why You Should Buy Kronos Worldwide Stock Right Now - MSN
Los Angeles Capital Management LLC Has $2.04 Million Holdings in Kronos Worldwide, Inc. (NYSE:KRO) - MarketBeat
Here's Why You Should Buy Kronos Worldwide Stock Right Now - Zacks Investment Research
Here's Why You Should Buy Kronos Worldwide Stock Right Now - Yahoo Finance
Los Angeles Capital Management LLC Raises Stock Holdings in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Zurcher Kantonalbank Zurich Cantonalbank Lowers Stock Holdings in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Bank of New York Mellon Corp Sells 1,458 Shares of Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Why Is Kronos Worldwide (KRO) Up 5.6% Since Last Earnings Report? - Yahoo Finance
Kronos Worldwide's Shares Rally 31% in 6 Months: Here's Why - MSN
Is Kronos Worldwide (KRO) Stock Outpacing Its Basic Materials Peers This Year? - Yahoo Finance
Is Kronos Worldwide (KRO) Stock Outpacing Its Basic Materials Peers This Year? - Nasdaq
(KRO) Technical Data - Stock Traders Daily
Ex-Dividend Reminder: Mueller Industries, Unifirst and Kronos Worldwide - Nasdaq
Kronos Worldwide's Shares Rally 31% in 6 Months: Here's Why - Yahoo Finance
[2024] Pigments Market is Expected to Boom in Coming Years by 2032 | CLARIANT, KRONOS Worldwide, DIC - EIN News
Kronos Worldwide, Inc. (NYSE:KRO) Sees Significant Growth in Short Interest - MarketBeat
Kronos Worldwide, Inc. (NYSE:KRO) Sees Large Increase in Short Interest - Defense World
Nisa Investment Advisors LLC Has $175,000 Position in Kronos Worldwide, Inc. (NYSE:KRO) - Defense World
Van Lanschot Kempen Investment Management N.V. Cuts Stock Position in Kronos Worldwide, Inc. (NYSE:KRO) - MarketBeat
Why You Should Add Kronos Worldwide (KRO) to Your Portfolio Now - MSN
Why You Should Add Kronos Worldwide (KRO) to Your Portfolio Now - Zacks Investment Research
Why You Should Add Kronos Worldwide (KRO) to Your Portfolio Now - Yahoo Finance
Kronos Worldwide Inc Stock (KRO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.57%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):